Literature DB >> 2585232

Lymphocyte phenotype does not predict immune function in pediatric patients infected with human immunodeficiency virus type 1.

J Petersen1, J Church, E Gomperts, R Parkman.   

Abstract

To determine whether assays of lymphocyte phenotype were predictive of antigen-specific immunologic function in children infected with human immunodeficiency virus type 1 (HIV-1), we compared the antigen-specific cellular and humoral functions (tetanus toxoid-induced T lymphocyte blastogenesis and anti-tetanus toxoid antibody) with the patients' T lymphocyte phenotype, determined at the same time. Although both HIV-1-infected patient populations studied (pediatric hemophilia patients and other pediatric patients) had decreases in the values determined by their functional and phenotypic assays, no association between the functional and phenotypic assays was demonstrated. Thus some HIV-1-infected patients with a normal phenotype had no antigen-specific function, whereas other patients with a markedly abnormal T lymphocyte phenotype had normal antigen specific T lymphocyte function. These results indicate that the assessment of HIV-1-infected patients should include assays of antigen-specific immune function in addition to assays of T lymphocyte phenotype.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585232     DOI: 10.1016/s0022-3476(89)80747-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

1.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  Effect of HIV vertical transmission on the ontogeny of T cell antigens involved in the regulation of humoral immune response.

Authors:  D Brugnoni; A Soresina; P Airo; A G Ugazio; L D Notarangelo; R Cattaneo; M Duse
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.